Literature DB >> 14569060

Role of receptor protein and membrane lipids in xanomeline wash-resistant binding to muscarinic M1 receptors.

Jan Jakubík1, Stanislav Tucek, Esam E El-Fakahany.   

Abstract

Xanomeline is a novel agonist functionally selective for muscarinic receptors of the M1 subtype. It binds to this receptor in two modes, reversible and quasi-irreversible (wash-resistant). We investigated the unknown mechanism of the wash-resistant binding in experiments with muscarinic M1 receptors expressed in transfected Chinese hamster ovary cells. Xanomeline's structure consists of two heterocycles and O-hexyl side chain. We compared the wash-resistant binding of xanomeline and its analogs with shorter O-alkyl side chains. For the wash-resistant binding to occur, the O-alkyl chain had to be at least O-butyl or longer. Accumulation of inositol phosphates was enhanced in washed cells that had been preexposed to xanomeline or its pentyl analog, whereas the agonistic effects of the methyl, propyl, and butyl analogs were abolished by washing. Only the reversible binding of xanomeline was detected purified soluble receptors, but both binding modes occurred purified receptors reconstituted into liposomes and exposed xanomeline only after reconstitution. The wash-resistant binding did not occur if the exposure of purified receptors or liposomes alone to xanomeline, followed by washing, reconstitution. Simultaneous presence of receptors and lipid environment is therefore essential for the binding to take place. We suggest that the binding of xanomeline involves interhelical penetration of M1 muscarinic receptor by xanomeline's O-alkyl chain and interaction with membrane lipids surrounding the receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14569060     DOI: 10.1124/jpet.103.058594

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Estimation of the dissociation rate of unlabelled ligand-receptor complexes by a 'two-step' competition binding approach.

Authors:  A Packeu; M Wennerberg; A Balendran; G Vauquelin
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  Long-term wash-resistant effects of brief interaction of xanomeline at the M1 muscarinic receptor.

Authors:  Kayla C De Lorme; Krista L Sikorski; Marianne K O Grant; Esam E El-Fakahany
Journal:  Neurosci Lett       Date:  2006-10-18       Impact factor: 3.046

3.  Cholinergic effects on fear conditioning II: nicotinic and muscarinic modulations of atropine-induced disruption of the degraded contingency effect.

Authors:  Sebastien Carnicella; Laure Pain; Philippe Oberling
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

4.  Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Pharmacology       Date:  2009-04-28       Impact factor: 2.547

5.  Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.

Authors:  Marianne K O Grant; Meredith J Noetzel; Kayla C De Lorme; Jan Jakubík; Vladimír Doležal; Esam E El-Fakahany
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

6.  Novel long-acting antagonists of muscarinic ACh receptors.

Authors:  Alena Randáková; Vladimír Rudajev; Vladimír Doležal; John Boulos; Jan Jakubík
Journal:  Br J Pharmacol       Date:  2018-04-14       Impact factor: 8.739

Review 7.  Multitargeting nature of muscarinic orthosteric agonists and antagonists.

Authors:  Jaromir Myslivecek
Journal:  Front Physiol       Date:  2022-09-06       Impact factor: 4.755

8.  Long-term activation upon brief exposure to xanomleline is unique to M1 and M4 subtypes of muscarinic acetylcholine receptors.

Authors:  Eva Šantrůčková; Vladimír Doležal; Esam E El-Fakahany; Jan Jakubík
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

Review 9.  Ligands, their receptors and ... plasma membranes.

Authors:  G Vauquelin; A Packeu
Journal:  Mol Cell Endocrinol       Date:  2009-07-30       Impact factor: 4.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.